CA2537648A1 - Compositions and methods for increasing muscle mass and strength, improving athletic performance, and/or reducing body fat mass leading to weight loss - Google Patents
Compositions and methods for increasing muscle mass and strength, improving athletic performance, and/or reducing body fat mass leading to weight loss Download PDFInfo
- Publication number
- CA2537648A1 CA2537648A1 CA002537648A CA2537648A CA2537648A1 CA 2537648 A1 CA2537648 A1 CA 2537648A1 CA 002537648 A CA002537648 A CA 002537648A CA 2537648 A CA2537648 A CA 2537648A CA 2537648 A1 CA2537648 A1 CA 2537648A1
- Authority
- CA
- Canada
- Prior art keywords
- testosterone
- extract
- levels
- red wine
- proanthocyanidins
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 48
- 238000000034 method Methods 0.000 title claims abstract description 23
- 210000003205 muscle Anatomy 0.000 title abstract description 16
- 230000037147 athletic performance Effects 0.000 title abstract description 14
- 210000000577 adipose tissue Anatomy 0.000 title description 13
- 230000004580 weight loss Effects 0.000 title description 13
- MUMGGOZAMZWBJJ-DYKIIFRCSA-N Testostosterone Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 MUMGGOZAMZWBJJ-DYKIIFRCSA-N 0.000 claims abstract description 98
- 229960003604 testosterone Drugs 0.000 claims abstract description 49
- 239000000284 extract Substances 0.000 claims abstract description 41
- 229940011871 estrogen Drugs 0.000 claims abstract description 18
- 239000000262 estrogen Substances 0.000 claims abstract description 18
- 102000009151 Luteinizing Hormone Human genes 0.000 claims abstract description 17
- 108010073521 Luteinizing Hormone Proteins 0.000 claims abstract description 17
- 229940040129 luteinizing hormone Drugs 0.000 claims abstract description 17
- 229920002770 condensed tannin Polymers 0.000 claims abstract description 15
- 238000009472 formulation Methods 0.000 claims description 23
- 230000000153 supplemental effect Effects 0.000 claims description 17
- 240000005739 Eurycoma longifolia Species 0.000 claims description 12
- 235000007882 dietary composition Nutrition 0.000 claims description 12
- 235000013761 grape skin extract Nutrition 0.000 claims description 12
- 238000006243 chemical reaction Methods 0.000 claims description 9
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 claims description 8
- 239000011777 magnesium Substances 0.000 claims description 5
- 229940112950 sage extract Drugs 0.000 claims description 5
- 235000020752 sage extract Nutrition 0.000 claims description 5
- 239000011701 zinc Substances 0.000 claims description 5
- GEPMAHVDJHFBJI-UHFFFAOYSA-N 7-[2-hydroxy-3-[2-hydroxyethyl(methyl)amino]propyl]-1,3-dimethylpurine-2,6-dione;pyridine-3-carboxylic acid Chemical compound OC(=O)C1=CC=CN=C1.CN1C(=O)N(C)C(=O)C2=C1N=CN2CC(O)CN(CCO)C GEPMAHVDJHFBJI-UHFFFAOYSA-N 0.000 claims description 4
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims description 4
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 claims description 4
- 229930182490 saponin Natural products 0.000 claims description 4
- 150000007949 saponins Chemical class 0.000 claims description 4
- 235000017709 saponins Nutrition 0.000 claims description 4
- 235000019158 vitamin B6 Nutrition 0.000 claims description 4
- 239000011726 vitamin B6 Substances 0.000 claims description 4
- 229940011671 vitamin b6 Drugs 0.000 claims description 4
- 229910052725 zinc Inorganic materials 0.000 claims description 4
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 claims description 3
- RDHQFKQIGNGIED-MRVPVSSYSA-N O-acetyl-L-carnitine Chemical compound CC(=O)O[C@H](CC([O-])=O)C[N+](C)(C)C RDHQFKQIGNGIED-MRVPVSSYSA-N 0.000 claims description 3
- 229910052749 magnesium Inorganic materials 0.000 claims description 3
- 238000011084 recovery Methods 0.000 abstract description 12
- VOXZDWNPVJITMN-ZBRFXRBCSA-N 17β-estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 VOXZDWNPVJITMN-ZBRFXRBCSA-N 0.000 abstract description 11
- 229960005309 estradiol Drugs 0.000 abstract description 11
- 229930182833 estradiol Natural products 0.000 abstract description 11
- 101000919395 Homo sapiens Aromatase Proteins 0.000 abstract description 7
- 102000044018 human CYP19A1 Human genes 0.000 abstract description 7
- 230000005764 inhibitory process Effects 0.000 abstract description 5
- 230000003247 decreasing effect Effects 0.000 abstract description 3
- 230000003213 activating effect Effects 0.000 abstract description 2
- 235000005911 diet Nutrition 0.000 abstract description 2
- 230000037213 diet Effects 0.000 abstract description 2
- 235000020095 red wine Nutrition 0.000 description 14
- 102000014654 Aromatase Human genes 0.000 description 11
- 108010078554 Aromatase Proteins 0.000 description 11
- 230000000694 effects Effects 0.000 description 5
- 230000004913 activation Effects 0.000 description 4
- 230000032683 aging Effects 0.000 description 4
- CVSVTCORWBXHQV-UHFFFAOYSA-N creatine Chemical compound NC(=[NH2+])N(C)CC([O-])=O CVSVTCORWBXHQV-UHFFFAOYSA-N 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 208000035475 disorder Diseases 0.000 description 3
- 230000002401 inhibitory effect Effects 0.000 description 3
- 230000002265 prevention Effects 0.000 description 3
- 230000009467 reduction Effects 0.000 description 3
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 235000021508 Coleus Nutrition 0.000 description 2
- 244000061182 Coleus blumei Species 0.000 description 2
- 206010010071 Coma Diseases 0.000 description 2
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 description 2
- RTIXKCRFFJGDFG-UHFFFAOYSA-N chrysin Chemical compound C=1C(O)=CC(O)=C(C(C=2)=O)C=1OC=2C1=CC=CC=C1 RTIXKCRFFJGDFG-UHFFFAOYSA-N 0.000 description 2
- 229960003624 creatine Drugs 0.000 description 2
- 239000006046 creatine Substances 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 230000036651 mood Effects 0.000 description 2
- 150000008442 polyphenolic compounds Chemical class 0.000 description 2
- 235000013824 polyphenols Nutrition 0.000 description 2
- 208000001076 sarcopenia Diseases 0.000 description 2
- 150000003515 testosterones Chemical class 0.000 description 2
- MEJYXFHCRXAUIL-UHFFFAOYSA-N 2-[carbamimidoyl(methyl)amino]acetic acid;hydrate Chemical compound O.NC(=N)N(C)CC(O)=O MEJYXFHCRXAUIL-UHFFFAOYSA-N 0.000 description 1
- NYCXYKOXLNBYID-UHFFFAOYSA-N 5,7-Dihydroxychromone Natural products O1C=CC(=O)C=2C1=CC(O)=CC=2O NYCXYKOXLNBYID-UHFFFAOYSA-N 0.000 description 1
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 1
- 241000404030 Anacyclus clavatus Species 0.000 description 1
- JEBFVOLFMLUKLF-IFPLVEIFSA-N Astaxanthin Natural products CC(=C/C=C/C(=C/C=C/C1=C(C)C(=O)C(O)CC1(C)C)/C)C=CC=C(/C)C=CC=C(/C)C=CC2=C(C)C(=O)C(O)CC2(C)C JEBFVOLFMLUKLF-IFPLVEIFSA-N 0.000 description 1
- 206010006187 Breast cancer Diseases 0.000 description 1
- 208000026310 Breast neoplasm Diseases 0.000 description 1
- 241000705930 Broussonetia papyrifera Species 0.000 description 1
- XGDLHLISLBPXPR-UHFFFAOYSA-N C.C1=CC=C2NC=CC2=C1.C1=CC=C2NC=CC2=C1 Chemical compound C.C1=CC=C2NC=CC2=C1.C1=CC=C2NC=CC2=C1 XGDLHLISLBPXPR-UHFFFAOYSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 description 1
- YJPIGAIKUZMOQA-UHFFFAOYSA-N Melatonin Natural products COC1=CC=C2N(C(C)=O)C=C(CCN)C2=C1 YJPIGAIKUZMOQA-UHFFFAOYSA-N 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 241001521901 Tribulus lanuginosus Species 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 241001593968 Vitis palmata Species 0.000 description 1
- 239000003098 androgen Substances 0.000 description 1
- 239000003886 aromatase inhibitor Substances 0.000 description 1
- 229940046844 aromatase inhibitors Drugs 0.000 description 1
- 238000005899 aromatization reaction Methods 0.000 description 1
- 235000013793 astaxanthin Nutrition 0.000 description 1
- MQZIGYBFDRPAKN-ZWAPEEGVSA-N astaxanthin Chemical compound C([C@H](O)C(=O)C=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C(=O)[C@@H](O)CC1(C)C MQZIGYBFDRPAKN-ZWAPEEGVSA-N 0.000 description 1
- 229940022405 astaxanthin Drugs 0.000 description 1
- 239000001168 astaxanthin Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 229960001948 caffeine Drugs 0.000 description 1
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 229940043370 chrysin Drugs 0.000 description 1
- 235000015838 chrysin Nutrition 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 229960004826 creatine monohydrate Drugs 0.000 description 1
- 101150047356 dec-1 gene Proteins 0.000 description 1
- 235000015872 dietary supplement Nutrition 0.000 description 1
- 231100000673 dose–response relationship Toxicity 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 150000002085 enols Chemical class 0.000 description 1
- 229940087603 grape seed extract Drugs 0.000 description 1
- 235000002532 grape seed extract Nutrition 0.000 description 1
- 229940094952 green tea extract Drugs 0.000 description 1
- 235000020688 green tea extract Nutrition 0.000 description 1
- 230000003054 hormonal effect Effects 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 229960003987 melatonin Drugs 0.000 description 1
- DRLFMBDRBRZALE-UHFFFAOYSA-N melatonin Chemical compound COC1=CC=C2NC=C(CCNC(C)=O)C2=C1 DRLFMBDRBRZALE-UHFFFAOYSA-N 0.000 description 1
- HVFSJXUIRWUHRG-UHFFFAOYSA-N oic acid Natural products C1CC2C3CC=C4CC(OC5C(C(O)C(O)C(CO)O5)O)CC(O)C4(C)C3CCC2(C)C1C(C)C(O)CC(C)=C(C)C(=O)OC1OC(COC(C)=O)C(O)C(O)C1OC(C(C1O)O)OC(COC(C)=O)C1OC1OC(CO)C(O)C(O)C1O HVFSJXUIRWUHRG-UHFFFAOYSA-N 0.000 description 1
- 235000017807 phytochemicals Nutrition 0.000 description 1
- 229930000223 plant secondary metabolite Natural products 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 230000003637 steroidlike Effects 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 210000001550 testis Anatomy 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 239000001717 vitis vinifera seed extract Substances 0.000 description 1
- 235000020097 white wine Nutrition 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/30—Zinc; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/46—Eucommiaceae (Eucommia family), e.g. hardy rubber tree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/537—Salvia (sage)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/87—Vitaceae or Ampelidaceae (Vine or Grape family), e.g. wine grapes, muscadine or peppervine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Abstract
Methods and compositions for the inhibition of human aromatase enzyme are presented for the purposes of increasing or activating the total levels of testosterone, free testosterone, and/or luteinizing hormone levels, while decreasing the levels of estrogen and estradiol. The increase in testosterone levels, combined with a proper exercise and diet regime may lead to increased muscle mass and strength, improved athletic performance and recovery and lead to an increase in lean body mass. Red Wine extracts containing Proanthocyanidins are employed to inhibit the action of the human aromatase enzyme.
Description
Compositions and Methods for Increasing Muscle Mass and Strength, Improving Athletic Performance, andlor Reducing Body Fat Mass Leading to Weight Loss Field of the Invention The present invention concerns compositions and methods for inhibiting the human aromatase enzyme to increase or activate total testosterone, free testosterone, and/or luteinizing hormone levels, for the purposes of increasing muscle mass and strength, improving athletic performance and recovery therefrom, and/or reducing body fat mass leading to weight loss.
In a preferred embodiment, the present invention concerns the use of red wine and its extracts to inhibit the aromatase enzyme within the human body, resulting in an increase in, or activation of, total testosterone, free testosterone and/or luteinizing hormone levels while simultaneously achieving a reduction in estrogen and/or estradiol levels, for the purposes of increasing muscle mass and strength, improving athletic performance and recovery therefrom, and/or reducing body fat mass leading to weight loss.
Summary of the Invention The present invention, according to one embodiment thereof, concerns compositions and methods for inhibiting the human aromatase enzyme to increase or activate total testosterone, free testosterone, and/or luteinizing hormone levels, for the purposes of increasing muscle mass and strength, improving athletic performance and recovery therefrom, and/or reducing body fat mass leading to weight loss.
In a preferred embodiment, the present invention concerns the use of red wine and its extracts to inhibit the aromatase enzyme within the human body, resulting in an increase in or activation of total testosterone, free testosterone and/or luteinizing hormone levels while simultaneously achieving a reduction in estrogen and/or estradiol levels for the purposes of increasing muscle mass and strength, improving athletic performance and recovery therefrom, and/or reducing body fat mass leading to weight loss.
In addition or alternatively, the present invention provides, according to various embodiments thereof, compositions and methods for increasing muscle mass and strength, improving athletic performance and recovery therefrom, and/or reducing body fat mass leading to weight loss, by increasing or activating total testosterone, free testosterone and/or luteinizing hormone levels while simultaneously reducing estrogen and/or estradiol levels.
In addition or alternatively, the present invention provides, according to various embodiments thereof, compositions and methods for improving memory and lean muscle mass, positively affecting mood, and/or the prevention of sarcopenia and/or other disorders commonly associated with aging.
Detailed Description of the Invention The present invention, according to various embodiments thereof, provides compositions and methods for increasing muscle mass and strength, improving athletic performance and recovery therefrom, and/or reducing body fat mass leading to weight loss. More specifically, the present invention provides for the use of red wine and its extracts to inhibit the human aromatase enzyme, resulting in an increase in or activation of total testosterone, free testosterone, and/or luteinizing hormone levels and a simultaneous decrease in estrogen and/or estradiol levels for the purposes of increasing muscle mass and strength, improving athletic performance and recovery therefrom, and/or reducing body fat mass leading to weight loss.
As a metabolite of testosterone, within the testes, a percentage of testosterone is converted to estradiol via aromatization (Harper's Biochemistry 25t" ed. Murray et al., 2000, Appleton and Lange, Toronto). Aromatase is the enzyme responsible for the conversion of androgen substrates, such as testosterone into estrogens. Proanthocyanidins from red wine extracts been shown to inhibit the action of aromatase activity (Eng ET, et al. Cancer Res.
Dec 1;63(23):8516-22). Therefore, the actions of proanthocyanidins inhibiting the human aromatase enzyme inhibits the conversion of testosterone to estradiol, thus leading to increased levels of free testosterone within the body.
The use of red wine extracts to inhibit the production of estradiol has also been employed in treatment of breast cancers.
The compositions of the present invention comprise red wine and/or its extracts. Certain polyphenols found in red wine, particularly Pinot Noir, Merlot, and Cabernet Sauvignon, may inhibit the human aromatase enzyme in a dose dependent manner. According to one embodiment, the present invention may employ extracts from red grapes and white button mushroom phytochemicals, as well as extracts of Broussonetia Papyrifera. In contrast, white wine and its extracts do not contain all of the same compounds as red wine and do not appear to have the ability to decrease the activity of aromatase, thus the present invention may provide further and significant inhibition of aromatase enzyme.
Aromatase enzymes may catalyze estrogen biosynthesis. Inhibition of aromatase with pharmaceutical non-steroidal aromatase inhibitors in normal healthy men may cause an increase in, or activation of, total testosterone, free testosterone and/or luteinizing hormone, with a subsequent decrease in estrogen and/or estradiol for the purposes of increasing muscle mass and strength, improving athletic performance and recovery therefrom, and/or reducing body fat mass leading to weight loss.
Although the present invention is not to be limited by any theoretical explanation, it is believed that inhibition of aromatase is a primary factor that increases or activates testosterone levels while simultaneously decreasing estrogen levels, and that certain polyphenols found in red wine and its extracts may inhibit aromatase activity. (t is believed that red wine and/or its extracts have a similar ability to increase or activate total testosterone, free testosterone and luteinizing hormone, with a subsequent decrease in estrogen and estradiol. It is believed that the increased or activated testosterone and/or luteinizing hormone levels lead to improvements in muscle mass and strength, athletic performance and recovery therefrom, and reductions in body fat mass leading to weight loss.
According to the invention there is provided a composition for increasing muscle mass and strength, improving athletic performance and recovery therefrom, andlor reducing body fat mass leading to weight loss, the composition comprising red wine and/or its extract. Suitable red wines and extracts thereof include, but are not limited to, Pinot Noirs, Merlots, and Cabernet Sauvignons.
Preferably, the composition is in the nature of a dietary supplement.
The supplement compositions according to the present invention may be employed in methods for increasing muscle mass and strength, improving athletic performance and recovery therefrom, and/or reducing body fat mass leading to weight loss by causing an inhibition of aromatase activity. The compositions of the present invention are particularly advantageous for athletes and bodybuilders to enhance performance. The amount of the composition which is administered to the athlete may vary depending on the desired effect, the body weight and characteristics of the athlete, and the like. For example, in preferred embodiments, the subject compositions comprising red wine and/or its extracts are administered to the diet of the athlete or bodybuilder on a daily basis.
The ability to increase or activate total testosterone, free testosterone, and/or luteinizing hormone levels while simultaneously decreasing estradiol and/or estrogen levels may also be desired in individuals having relatively low testosterone levels, for example hypogonadal older men.
According to a further aspect of the invention there is provided a method for improving memory and lean muscle mass, positively effecting mood, and/or for the prevention of sarcopenia and other disorders commonly associated with aging. This is particularly desired, for example, by the aging male population in the prevention of disorders commonly associated with aging.
In a preferred embodiment, the present invention concerns the use of red wine and its extracts to inhibit the aromatase enzyme within the human body, resulting in an increase in, or activation of, total testosterone, free testosterone and/or luteinizing hormone levels while simultaneously achieving a reduction in estrogen and/or estradiol levels, for the purposes of increasing muscle mass and strength, improving athletic performance and recovery therefrom, and/or reducing body fat mass leading to weight loss.
Summary of the Invention The present invention, according to one embodiment thereof, concerns compositions and methods for inhibiting the human aromatase enzyme to increase or activate total testosterone, free testosterone, and/or luteinizing hormone levels, for the purposes of increasing muscle mass and strength, improving athletic performance and recovery therefrom, and/or reducing body fat mass leading to weight loss.
In a preferred embodiment, the present invention concerns the use of red wine and its extracts to inhibit the aromatase enzyme within the human body, resulting in an increase in or activation of total testosterone, free testosterone and/or luteinizing hormone levels while simultaneously achieving a reduction in estrogen and/or estradiol levels for the purposes of increasing muscle mass and strength, improving athletic performance and recovery therefrom, and/or reducing body fat mass leading to weight loss.
In addition or alternatively, the present invention provides, according to various embodiments thereof, compositions and methods for increasing muscle mass and strength, improving athletic performance and recovery therefrom, and/or reducing body fat mass leading to weight loss, by increasing or activating total testosterone, free testosterone and/or luteinizing hormone levels while simultaneously reducing estrogen and/or estradiol levels.
In addition or alternatively, the present invention provides, according to various embodiments thereof, compositions and methods for improving memory and lean muscle mass, positively affecting mood, and/or the prevention of sarcopenia and/or other disorders commonly associated with aging.
Detailed Description of the Invention The present invention, according to various embodiments thereof, provides compositions and methods for increasing muscle mass and strength, improving athletic performance and recovery therefrom, and/or reducing body fat mass leading to weight loss. More specifically, the present invention provides for the use of red wine and its extracts to inhibit the human aromatase enzyme, resulting in an increase in or activation of total testosterone, free testosterone, and/or luteinizing hormone levels and a simultaneous decrease in estrogen and/or estradiol levels for the purposes of increasing muscle mass and strength, improving athletic performance and recovery therefrom, and/or reducing body fat mass leading to weight loss.
As a metabolite of testosterone, within the testes, a percentage of testosterone is converted to estradiol via aromatization (Harper's Biochemistry 25t" ed. Murray et al., 2000, Appleton and Lange, Toronto). Aromatase is the enzyme responsible for the conversion of androgen substrates, such as testosterone into estrogens. Proanthocyanidins from red wine extracts been shown to inhibit the action of aromatase activity (Eng ET, et al. Cancer Res.
Dec 1;63(23):8516-22). Therefore, the actions of proanthocyanidins inhibiting the human aromatase enzyme inhibits the conversion of testosterone to estradiol, thus leading to increased levels of free testosterone within the body.
The use of red wine extracts to inhibit the production of estradiol has also been employed in treatment of breast cancers.
The compositions of the present invention comprise red wine and/or its extracts. Certain polyphenols found in red wine, particularly Pinot Noir, Merlot, and Cabernet Sauvignon, may inhibit the human aromatase enzyme in a dose dependent manner. According to one embodiment, the present invention may employ extracts from red grapes and white button mushroom phytochemicals, as well as extracts of Broussonetia Papyrifera. In contrast, white wine and its extracts do not contain all of the same compounds as red wine and do not appear to have the ability to decrease the activity of aromatase, thus the present invention may provide further and significant inhibition of aromatase enzyme.
Aromatase enzymes may catalyze estrogen biosynthesis. Inhibition of aromatase with pharmaceutical non-steroidal aromatase inhibitors in normal healthy men may cause an increase in, or activation of, total testosterone, free testosterone and/or luteinizing hormone, with a subsequent decrease in estrogen and/or estradiol for the purposes of increasing muscle mass and strength, improving athletic performance and recovery therefrom, and/or reducing body fat mass leading to weight loss.
Although the present invention is not to be limited by any theoretical explanation, it is believed that inhibition of aromatase is a primary factor that increases or activates testosterone levels while simultaneously decreasing estrogen levels, and that certain polyphenols found in red wine and its extracts may inhibit aromatase activity. (t is believed that red wine and/or its extracts have a similar ability to increase or activate total testosterone, free testosterone and luteinizing hormone, with a subsequent decrease in estrogen and estradiol. It is believed that the increased or activated testosterone and/or luteinizing hormone levels lead to improvements in muscle mass and strength, athletic performance and recovery therefrom, and reductions in body fat mass leading to weight loss.
According to the invention there is provided a composition for increasing muscle mass and strength, improving athletic performance and recovery therefrom, andlor reducing body fat mass leading to weight loss, the composition comprising red wine and/or its extract. Suitable red wines and extracts thereof include, but are not limited to, Pinot Noirs, Merlots, and Cabernet Sauvignons.
Preferably, the composition is in the nature of a dietary supplement.
The supplement compositions according to the present invention may be employed in methods for increasing muscle mass and strength, improving athletic performance and recovery therefrom, and/or reducing body fat mass leading to weight loss by causing an inhibition of aromatase activity. The compositions of the present invention are particularly advantageous for athletes and bodybuilders to enhance performance. The amount of the composition which is administered to the athlete may vary depending on the desired effect, the body weight and characteristics of the athlete, and the like. For example, in preferred embodiments, the subject compositions comprising red wine and/or its extracts are administered to the diet of the athlete or bodybuilder on a daily basis.
The ability to increase or activate total testosterone, free testosterone, and/or luteinizing hormone levels while simultaneously decreasing estradiol and/or estrogen levels may also be desired in individuals having relatively low testosterone levels, for example hypogonadal older men.
According to a further aspect of the invention there is provided a method for improving memory and lean muscle mass, positively effecting mood, and/or for the prevention of sarcopenia and other disorders commonly associated with aging. This is particularly desired, for example, by the aging male population in the prevention of disorders commonly associated with aging.
Example 1 provides, in accordance with one embodiment of the present invention, a continuous, 24 hour testosterone support formulation. In this embodiment, the formulation provides for two supplemental dietary compositions, e.g., a daytime supplemental dietary composition and a night-time supplemental dietary composition, although any number of formulations may be provided throughout the day. Advantageously, both the day-time and night-time formulations of the supplemental dietary composition may include at least Eurycoma Longifolia, Grape Skin Extract and Red Wine Extract to provide proanthocyanidins. In addition, the night-time formulation may also include a blend of Zinc, Magnesium and Vitamin B6. Also, the day-time formulation may include Tibulus terrestris supplying Saponins, Acetyl-L-Carnitine, Xanthinol Nicotinate and/or Clary Sage Extract, supplying Sclareolides.
This dual-action formulation provides for improved testosterone support throughout the day by maintaining healthy testosterone levels during the a.m.
and p.m. hours. It may do this by responding to male hormonal changes that occur naturally throughout the day. For example, in the morning, when testosterone levels are typically higher, the a.m. formulation helps reduce the conversion of testosterone to estrogen. Later in the day, when testosterone levels are typically reduced and are at their lowest levels, the p.m. formula works to increase testosterone levels. In this manner, testosterone levels may be maintained and supported more effectively throughout the day.
Although the following examples illustrate the practice of the present invention in some of its embodiments, the examples should not be construed as limiting the scope of the invention. Other embodiments will be apparent to one skilled in the art from consideration of the specification and examples.
This dual-action formulation provides for improved testosterone support throughout the day by maintaining healthy testosterone levels during the a.m.
and p.m. hours. It may do this by responding to male hormonal changes that occur naturally throughout the day. For example, in the morning, when testosterone levels are typically higher, the a.m. formulation helps reduce the conversion of testosterone to estrogen. Later in the day, when testosterone levels are typically reduced and are at their lowest levels, the p.m. formula works to increase testosterone levels. In this manner, testosterone levels may be maintained and supported more effectively throughout the day.
Although the following examples illustrate the practice of the present invention in some of its embodiments, the examples should not be construed as limiting the scope of the invention. Other embodiments will be apparent to one skilled in the art from consideration of the specification and examples.
EXAMPLES
Example 1 Ingredients (PM 2.710 Active Formula Formulation) glservingConstituents Ise rvi n ZMA Blend (Zinc, Mg, 2.400 0.0324*Zn 88.5609%
Vitamin B6) 0.490*Mg 0.01248*Vitamin Grape Skin Extract (stdØ050 0.01 1.8450%
to 20% Proanthoc anidins Proanthoc anidins Red Wine Extract (std. 0.250 0.0625 9.2251%
to 25% Proanthoc anidins) Proanthocyanidins Eurycoma Longifolia 0.010 0.3690%
(50:1 Extract from root Total 2.710 100%
Ingredients (AM 2.235 Active Formula Formulation g/servingConstituents /servin Tibulus terrestris from0.100 0.045 Saponins 4.4743%
whole lant 45% Sa onins Acet I-L-Carnitine 0.500 22.3714%
Grape Skin Extract (stdØ50 0.05 11 to 1857%
20% Proanthoc anidins Proanthocyanidins.
Red Wine Extract (std. 1.250 0.3125 55.9284%
to 25% Proanthoc anidins Proanthoc anidins Eurycoma Longifolia 0.010 0.4474%
(50:1 Extract from root Xanthinol Nicotinate 0.100 4.4743%
Clary Sage Extract from0.025 0.0025 1 1186%
Whole plant (10% Sclareolides .
Sclareolides Total 2.235 100%
In redient Iservin Exam le 2 Red Wine Extract 0.500 Exam to 3 Tribulus terrestris 0.100 Acet I-L-Carnitine 0.500 Grape Seed Extract 0.500 Red Wine Extract 1.250 Coleus Forskhoii 0.025 Eu coma Lon ifolia 0.020 Clary Sage Extract 10% ~ 0.025 Example 4 ZMA Blend 2.400 Gra a Seed Extract 0.500 Red Wine Extract 0.250 Eu coma Lon ifolia 0.020 Example 5 Creatine Monoh drate 3.000 Melatonin 0.030 Red Wine Extract 0.500 Exam le 6 Creatine Monoh drate 5.000 AI ha Li oic Acid 0.250 Red Wine Extract 0.250 Exam le 7 Red Wine Extract 0.050 Gra a skin Extract 0.050 Coenz me Q 10 0.025 Astaxanthin 0.025 P cno enol 0.005 N-Acetyl-C steine 0.012 Vitamin C 0.012 Exam le 8 Red Wine Extract 0.100 Whe Protein 20.000 Creatine Monohydrate 3.000 Exam le 9 Red Wine extract 0.150 Green Tea Extract 0.200 Caffeine 0.200 Exam le 10 Red wine Extract 0.400 Di-indole Methane 0.170 Chrysin 0.100 Coleus Forskholii 0.250 Example 11 Delta-4-1012-dimethyl-cyclopent-0.300 a-phenantrene-3617-trion Red Wine Extract 0.300
Example 1 Ingredients (PM 2.710 Active Formula Formulation) glservingConstituents Ise rvi n ZMA Blend (Zinc, Mg, 2.400 0.0324*Zn 88.5609%
Vitamin B6) 0.490*Mg 0.01248*Vitamin Grape Skin Extract (stdØ050 0.01 1.8450%
to 20% Proanthoc anidins Proanthoc anidins Red Wine Extract (std. 0.250 0.0625 9.2251%
to 25% Proanthoc anidins) Proanthocyanidins Eurycoma Longifolia 0.010 0.3690%
(50:1 Extract from root Total 2.710 100%
Ingredients (AM 2.235 Active Formula Formulation g/servingConstituents /servin Tibulus terrestris from0.100 0.045 Saponins 4.4743%
whole lant 45% Sa onins Acet I-L-Carnitine 0.500 22.3714%
Grape Skin Extract (stdØ50 0.05 11 to 1857%
20% Proanthoc anidins Proanthocyanidins.
Red Wine Extract (std. 1.250 0.3125 55.9284%
to 25% Proanthoc anidins Proanthoc anidins Eurycoma Longifolia 0.010 0.4474%
(50:1 Extract from root Xanthinol Nicotinate 0.100 4.4743%
Clary Sage Extract from0.025 0.0025 1 1186%
Whole plant (10% Sclareolides .
Sclareolides Total 2.235 100%
In redient Iservin Exam le 2 Red Wine Extract 0.500 Exam to 3 Tribulus terrestris 0.100 Acet I-L-Carnitine 0.500 Grape Seed Extract 0.500 Red Wine Extract 1.250 Coleus Forskhoii 0.025 Eu coma Lon ifolia 0.020 Clary Sage Extract 10% ~ 0.025 Example 4 ZMA Blend 2.400 Gra a Seed Extract 0.500 Red Wine Extract 0.250 Eu coma Lon ifolia 0.020 Example 5 Creatine Monoh drate 3.000 Melatonin 0.030 Red Wine Extract 0.500 Exam le 6 Creatine Monoh drate 5.000 AI ha Li oic Acid 0.250 Red Wine Extract 0.250 Exam le 7 Red Wine Extract 0.050 Gra a skin Extract 0.050 Coenz me Q 10 0.025 Astaxanthin 0.025 P cno enol 0.005 N-Acetyl-C steine 0.012 Vitamin C 0.012 Exam le 8 Red Wine Extract 0.100 Whe Protein 20.000 Creatine Monohydrate 3.000 Exam le 9 Red Wine extract 0.150 Green Tea Extract 0.200 Caffeine 0.200 Exam le 10 Red wine Extract 0.400 Di-indole Methane 0.170 Chrysin 0.100 Coleus Forskholii 0.250 Example 11 Delta-4-1012-dimethyl-cyclopent-0.300 a-phenantrene-3617-trion Red Wine Extract 0.300
Claims (18)
1. ~A supplemental dietary composition for at least one of reducing the conversion of testosterone to estrogen, increasing luteinizing hormone levels, and increasing free testosterone levels, the composition comprising:
Eurycoma Longifolia;
Grape Skin Extract; and Red Wine Extract to provide proanthocyanidins.
Eurycoma Longifolia;
Grape Skin Extract; and Red Wine Extract to provide proanthocyanidins.
2. ~The supplemental dietary composition of claim 1, wherein a day-time and a night-time formulation are provided separately.
3. ~The supplemental composition of claim 2, wherein the night-time formulation further comprises a blend of Zinc, Magnesium and Vitamin B6.
4. ~The supplemental composition of claim 2, wherein the daytime formulation further comprises Tibulus terrestris supplying Saponins.
5. ~The supplemental composition of claim 2, wherein the daytime formulation further comprises Acetyl-L-Carnitine.
6. ~The supplemental composition of claim 2, wherein the daytime formulation further comprises Xanthinol Nicotinate.
7. ~The supplemental composition of claim 2, wherein the daytime formulation further comprises Clary Sage Extract, supplying Sclareolides.
8. ~A method for at least one of reducing the conversion of testosterone to estrogen, increasing luteinizing hormone levels, and increasing free testosterone levels, the method comprising the steps of:
ingesting a night-time supplemental dietary composition that includes at least Eurycoma Longifolia, Grape Skin Extract and Red Wine Extract to provide proanthocyanidins.
ingesting a night-time supplemental dietary composition that includes at least Eurycoma Longifolia, Grape Skin Extract and Red Wine Extract to provide proanthocyanidins.
9. ~A method for at least one of reducing the conversion of testosterone to estrogen, increasing luteinizing hormone levels, and increasing free testosterone levels, the method comprising the steps of:
ingesting a daytime supplemental dietary composition that includes at least Eurycoma Longifolia, Grape Skin Extract and Red Wine Extract to provide proanthocyanidins.
ingesting a daytime supplemental dietary composition that includes at least Eurycoma Longifolia, Grape Skin Extract and Red Wine Extract to provide proanthocyanidins.
10. ~The method of claim 8, wherein the night-time formulation further comprises a blend of Zinc, Magnesium and Vitamin B6.
11. ~The method of claim 9, wherein the daytime formulation further comprises Tibulus terrestris supplying Saponins.
12. ~The method of claim 9, wherein the daytime formulation further comprises~
Acetyl-L-Carnitine.
Acetyl-L-Carnitine.
13. ~The method of claim 9, wherein the daytime formulation further comprises Xanthinol Nicotinate.
14. ~The method of claim 9, wherein the daytime formulation further comprises Clary Sage Extract, supplying Sclareolides.
15. ~The method of claim 8, wherein the Eurycoma Longifolia, Grape Skin Extract and Red Wine Extract providing proanthocyanidins are present in an amount effective to at least one of reduce the conversion of~
testosterone to estrogen, increase luteinizing hormone levels and increase free testosterone levels.
testosterone to estrogen, increase luteinizing hormone levels and increase free testosterone levels.
16.~The method of claim 9, wherein the Eurycoma Longifolia, Grape Skin Extract and Red Wine Extract providing proanthocyanidins are present in an amount effective to at least one of reduce the conversion of testosterone to estrogen, increase luteinizing hormone levels and increase free testosterone levels.
17. ~A method for providing a continuous, 24 hour testosterone support formulation by at least one of reducing the conversion of testosterone to estrogen, increasing luteinizing hormone levels, and increasing free testosterone levels, the method comprising the steps of:
ingesting a daytime supplemental dietary composition that includes at least Eurycoma Longifolia, Grape Skin Extract and Red Wine Extract to provide proanthocyanidins.
ingesting a night-time supplemental dietary composition that includes at feast Eurycoma Longifolia, Grape Skin Extract and Red Wine Extract to provide proanthocyanidins.
ingesting a daytime supplemental dietary composition that includes at least Eurycoma Longifolia, Grape Skin Extract and Red Wine Extract to provide proanthocyanidins.
ingesting a night-time supplemental dietary composition that includes at feast Eurycoma Longifolia, Grape Skin Extract and Red Wine Extract to provide proanthocyanidins.
18. ~A continuous, 24 hour testosterone support formulation comprising:
a daytime supplemental dietary composition that includes at least Eurycoma Longifolia, Grape Skin Extract and Red Wine Extract to provide proanthocyanidins.
a night-time supplemental dietary composition that includes at least Eurycoma Longifolia, Grape Skin Extract and Red Wine Extract to provide proanthocyanidins.
a daytime supplemental dietary composition that includes at least Eurycoma Longifolia, Grape Skin Extract and Red Wine Extract to provide proanthocyanidins.
a night-time supplemental dietary composition that includes at least Eurycoma Longifolia, Grape Skin Extract and Red Wine Extract to provide proanthocyanidins.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US65761505P | 2005-02-28 | 2005-02-28 | |
US60/657,615 | 2005-02-28 |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2537648A1 true CA2537648A1 (en) | 2006-08-28 |
Family
ID=36938960
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002537648A Abandoned CA2537648A1 (en) | 2005-02-28 | 2006-02-24 | Compositions and methods for increasing muscle mass and strength, improving athletic performance, and/or reducing body fat mass leading to weight loss |
Country Status (2)
Country | Link |
---|---|
US (1) | US20060193923A1 (en) |
CA (1) | CA2537648A1 (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8613959B2 (en) * | 2009-02-10 | 2013-12-24 | Fhg Corporation | Dietary supplements containing extracts of Nelumbo and processes of using same |
US20090306031A1 (en) * | 2009-08-07 | 2009-12-10 | Kneller Bruce W | 5alpha-ANDROSTANE-3,6,17-TRIONE (KNELLER'S TRIONE) AND METHODS OF USE THEREFOR |
WO2011016814A1 (en) * | 2009-08-07 | 2011-02-10 | Kneller Bruce W | 5α-ANDROSTANE-3,6,17-TRIONE (KNELLER'S TRIONE) AND METHODS OF USE THEREFOR |
WO2012097061A1 (en) * | 2011-01-13 | 2012-07-19 | Abbott Laboratories | Nutritional compositions and methods for improving skeletal muscle protein metabolism |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4647450A (en) * | 1983-07-20 | 1987-03-03 | Warner-Lambert Company | Chewing gum compositions containing magnesium trisilicate absorbates |
US4917913A (en) * | 1989-09-29 | 1990-04-17 | International Flavors & Fragrances Inc. | Use of sclareolide in augmenting or enhancing the organoleptic properties of foodstuffs |
US5945546A (en) * | 1997-03-25 | 1999-08-31 | Subbiah; Ven | Purification of sclareolide |
US6117429A (en) * | 1997-08-11 | 2000-09-12 | Weider Nutrition International, Inc | Compositions and treatments for reducing potential unwanted side effects associated with long-term administration of androgenic testosterone precursors |
US6534086B1 (en) * | 2000-03-06 | 2003-03-18 | Metagenics, Inc. | Composition and method for treatment of inflammation and pain in mammals |
US7132117B2 (en) * | 2000-08-29 | 2006-11-07 | Government Of Malaysia | Bioactive fraction of Eurycoma longifolia |
GB0026018D0 (en) * | 2000-10-24 | 2000-12-13 | Novartis Nutrition Ag | New composition |
US6790465B2 (en) * | 2000-12-01 | 2004-09-14 | Snore-Fix, Inc. | Composition and method for treating snoring |
KR100858768B1 (en) * | 2001-06-21 | 2008-09-16 | 교와 핫꼬 고교 가부시끼가이샤 | Process for Producing Plant Extract Containing Plant Powder |
EP1304048B1 (en) * | 2001-10-22 | 2004-09-22 | Ivo Pera | Composition to reduce or quit smoking addiction |
US7670612B2 (en) * | 2002-04-10 | 2010-03-02 | Innercap Technologies, Inc. | Multi-phase, multi-compartment capsular delivery apparatus and methods for using same |
US20040001817A1 (en) * | 2002-05-14 | 2004-01-01 | Giampapa Vincent C. | Anti-aging nutritional supplement |
US20040146539A1 (en) * | 2003-01-24 | 2004-07-29 | Gupta Shyam K. | Topical Nutraceutical Compositions with Selective Body Slimming and Tone Firming Antiaging Benefits |
-
2006
- 2006-02-24 US US11/361,799 patent/US20060193923A1/en not_active Abandoned
- 2006-02-24 CA CA002537648A patent/CA2537648A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
US20060193923A1 (en) | 2006-08-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Borghi et al. | Nutraceuticals with a clinically detectable blood pressure‐lowering effect: a review of available randomized clinical trials and their meta‐analyses | |
AU2011100294A4 (en) | Formulations and treatments for trichology | |
JP5084512B2 (en) | Antioxidant dietary supplement compositions and methods for maintaining healthy skin | |
EP2491938B1 (en) | Formulations for well-being | |
US5547671A (en) | Anti-intoxication composition | |
US20080254135A1 (en) | Resveratrol-containing compositions for general health and vitality | |
JP6530362B2 (en) | Skin cosmetics | |
US20030064937A1 (en) | Composition for reducing appetite in mammals | |
JP2010106022A (en) | Composition including medicine for decreasing cellulite and unaesthetic appearance associated with cellulite, and drug product including the composition | |
US11116747B2 (en) | Compositions comprising proanthocyanidins and oenothein B | |
CA2537648A1 (en) | Compositions and methods for increasing muscle mass and strength, improving athletic performance, and/or reducing body fat mass leading to weight loss | |
WO2011116220A2 (en) | Oral supplement | |
US6551628B1 (en) | Herbal intestinal tract cleanser | |
FR2908604A1 (en) | Food supplement useful to prevent or fight against androgenic alopecia, hair loss, the hyperseborrhea, acne and hirsutism, comprises green tea extract, another plant extract comprising quercetin and zinc | |
WO2008138115A1 (en) | Nutritional composition comprising l-carmtme fumarate, red wine extract and saw palmetto extract for maintaining skeletal muscle androgen receptivity | |
US10172826B2 (en) | Composition and method to treat and alleviate symptoms of hot flashes in a female subject | |
WO2012063198A1 (en) | Compositions for the prevention and treatment of erectile dysfunction and impotence and for improving sport performance | |
US11850451B2 (en) | Cosmetic compositions and methods for improving skin conditions | |
EP1074254A3 (en) | Use of plant polyphenols with vitamines for treating iron overload | |
Shahwan et al. | Neuroprotective antioxidant effect of Portulaca quadrifida Linn. Leaves extract on immobilization stress-induced changes in rat's brain | |
CA2539229C (en) | Oral compositions comprising vitis vinifera, gingko biloba and centella asiatica for the treatment of cellulite | |
CA3026026A1 (en) | Nutritional supplements for increasing male testosterone levels | |
FR2898059A1 (en) | Phytohormonal composition useful to prevent and fight against (pre)menopausal disorders e.g. hot flashes, night sweats, fatigability and mood and sleep disorders, comprises combination of herbal extracts rich in lignans and sage extract | |
KR101791574B1 (en) | Pharmaceutical composition for preventing or treating female menopausal disorder comprising an extract of black rice aleurone layer | |
US20200179426A1 (en) | Methods of use for oenothein a and b from epilobium species |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
FZDE | Dead |
Effective date: 20140225 |